版本:
中国

BRIEF-Selecta Biosciences commences dosing in Phase 1 clinical trial of nicotine vaccine for smoking cessation and relapse prevention

May 11 Selecta Biosciences Inc

* Selecta Biosciences commences dosing in Phase 1 clinical trial of nicotine vaccine for smoking cessation and relapse prevention Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐